Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (800) 227-6666


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C54456-100 100 µg (0.5 mg/ml) $503 
ADRB2 Antibody - ADRB2R / ADRB2 antibody (0.5µg/ml) staining of HepG2 cell ysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
ADRB2 Antibody - Antibody (0.2 ug/ml) staining of human liver lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
ADRB2 Antibody - ADRB2R / ADRB2 antibody (0.5µg/ml) staining of HepG2 cell ysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
ADRB2 Antibody - Antibody (0.2 ug/ml) staining of human liver lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
1 of 2
2 of 2

Polyclonal Goat anti‑Human ADRB2 Antibody (aa390‑402, WB) LS‑C54456

Polyclonal Goat anti‑Human ADRB2 Antibody (aa390‑402, WB) LS‑C54456

Note: This antibody replaces LS-C63767
Antibody:
ADRB2 Goat anti-Human Polyclonal (aa390-402) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human, Monkey
Format:
Unconjugated, Unmodified
Price
Catalog Number
$503
LS-C54456-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
ADRB2 Goat anti-Human Polyclonal (aa390-402) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human, Monkey
Format:
Unconjugated, Unmodified

Specifications

Description
ADRB2 antibody LS-C54456 is an unconjugated goat polyclonal antibody to ADRB2 (aa390-402) from human. It is reactive with human and monkey. Validated for Peptide-ELISA and WB. Cited in 1 publication.
Target
Human ADRB2
Synonyms
ADRB2 | ADRB2R | Adrenoceptor beta 2, surface | ADRBR | B2AR | Beta-2 adrenoceptor | Beta-2 adrenergic receptor | Beta-2 adrenoreceptor | BETA2AR | BAR | Adrenergic beta-2 receptor | Catecholamine receptor
Host
Goat
Reactivity
Human, Monkey (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Modifications
Unmodified
Immunogen
Peptide with sequence C-HQGTVPSDNIDSQ, from the C-Terminus of protein sequence according to NP_000015.1.
Epitope
aa390-402
Specificity
Human ADRB2.
Applications
  • Western blot (0.3 - 1 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:16000)
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ADRB2
P07550 NM_000024 NP_000015.1

LSBio Ratings

ADRB2 Antibody (aa390-402) for WB/Western LS-C54456 has an LSBio Rating of
Publications (4)

Publications (1)

Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism. McCormick C, Alexandre L, Thompson J, Mutungi G. Journal of applied physiology (Bethesda, Md. : 1985). 2010 Dec;109:1716-27.

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/12/2024